Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
about
Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data.Medication use following bariatric surgery: factors associated with early discontinuation.The use of drugs in patients who have undergone bariatric surgeryCardiovascular benefits of bariatric surgery in morbidly obese patients.Course of depressive symptoms and treatment in the longitudinal assessment of bariatric surgery (LABS-2) study.Impact of bariatric surgery on health care utilization and costs among patients with diabetesMedication Use Among Patients Prior to Bariatric Surgery.Medication Use by Race and Ethnicity in Women Transitioning Through the Menopause: A Study of Women's Health Across the Nation Drug Epidemiology Study.Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m²Screening and diagnosis of micronutrient deficiencies before and after bariatric surgery.Bariatric surgery: cost-effectiveness and budget impact.Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes.Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications.Psychopharmacology and Bariatric Surgery.The Impact of Bariatric Surgery on Thyroid Function and Medication Use in Patients with Hypothyroidism.The Impact of Laparoscopic Adjustable Gastric Banding on an NHS Cohort of Type 2 Diabetics: a Prospective Cohort Study.Influence of bariatric surgery on the use of medication.Medication and nutritional supplement use before and after bariatric surgery.Pharmaceutical utilisation and costs before and after bariatric surgery.Laparoscopic sleeve gastrectomy in patients over 59 years: early recovery and 12-month follow-up.Five-year changes in psychiatric treatment status and weight-related comorbidities following bariatric surgery in a veteran population.Investigation of antidepressant medication usage after bariatric surgery.Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients.Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery.Impact of bariatric surgery on the medical management and costs of obese patients in France: an analysis of a national representative claims database.
P2860
Q33554109-4D1F0CAE-1567-4674-BA6D-C4B2F7E60891Q33591031-B6CB18D1-73BE-462D-BC42-9BBD55DAAA0DQ33633328-C96729D5-E1F3-48AF-ABD1-BE5AE5AE0326Q33829180-4B991385-E479-46B6-81FE-B283A4609E86Q33969243-D92AC2AA-F999-4D41-9289-8E09E0A2C5DFQ35619737-FE62F962-F243-4E38-8E7C-CAE4E253FF3AQ36074064-941839CA-0197-4331-BB7A-0049783D7B32Q36987455-C9E1884E-D88C-41D9-84D0-8FD446C42315Q37040474-EDB3E07B-FE21-43F3-9626-4F3CCBCA6418Q37086448-1C21F118-3574-4A8F-AE70-364D55F55A6FQ37980050-19ED3BC0-BF4C-47B6-9405-B9B64529B6AAQ38083603-2D1DFA74-7DD3-4098-A85F-2A2831D5D1BBQ38524401-843F9380-05CF-4E29-9185-5D9C3531A378Q38580433-544A3DF1-2804-4409-818B-847D3DF05924Q38931751-7B5ADC91-1E42-4541-B9B5-FCFC22DADE8AQ40147231-FD52CD5E-5AD2-41FE-B0FD-200A54A90027Q40365571-57DBE426-5E53-4076-B019-825AECF883E5Q40489993-D87E2A35-7716-49FC-AC23-BFA071C910A3Q43680895-E2888C98-F0EC-43D5-AE73-78DE28842F70Q44028724-7F5EC76B-5A47-4096-9515-202F2C67C75DQ44120062-6728033A-9F76-4AF2-83B2-0EB641E6AB66Q44176317-6A1B8705-CAA9-4A98-BCB1-5490A84DAEE3Q48098765-C6CF1CFE-E73D-4233-87D4-708FDE9BCBC4Q50494665-92BC2D6C-6749-493E-9244-57563EED629AQ51263663-7AE63FC3-CBC9-4C8B-9CAF-C55362FA02DD
P2860
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
@ast
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
@en
type
label
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
@ast
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
@en
prefLabel
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
@ast
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
@en
P2093
P1433
P1476
Prompt reduction in use of medications for comorbid conditions after bariatric surgery.
@en
P2093
Albert W Wu
Andrew D Shore
Eric B Bass
Francesca Dominici
Jeanne M Clark
Jodi B Segal
Jonathan P Weiner
Martin A Makary
Thomas M Richards
Thomas Magnuson
P2888
P304
P356
10.1007/S11695-009-9960-1
P577
2009-12-01T00:00:00Z